BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 11414365)

  • 61. C1q receptors: regulating specific functions of phagocytic cells.
    Tenner AJ
    Immunobiology; 1998 Aug; 199(2):250-64. PubMed ID: 9777410
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mam33p, an oligomeric, acidic protein in the mitochondrial matrix of Saccharomyces cerevisiae is related to the human complement receptor gC1q-R.
    Seytter T; Lottspeich F; Neupert W; Schwarz E
    Yeast; 1998 Mar; 14(4):303-10. PubMed ID: 9559539
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The soluble recombinant form of a binding protein/receptor for the globular domain of C1q (gC1qR) enhances blood coagulation.
    Peerschke EI; Jesty J; Reid KB; Ghebrehiwet B
    Blood Coagul Fibrinolysis; 1998 Jan; 9(1):29-37. PubMed ID: 9607116
    [TBL] [Abstract][Full Text] [Related]  

  • 64. C1q-binding proteins and C1q receptors.
    Nicholson-Weller A; Klickstein LB
    Curr Opin Immunol; 1999 Feb; 11(1):42-6. PubMed ID: 10047536
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cloning of the mouse homolog of the 126-kDa human C1q/MBL/SP-A receptor, C1qR(p).
    Norsworthy PJ; Taylor PR; Walport MJ; Botto M
    Mamm Genome; 1999 Aug; 10(8):789-93. PubMed ID: 10430665
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage.
    Sansonno D; Tucci FA; Ghebrehiwet B; Lauletta G; Peerschke EI; Conteduca V; Russi S; Gatti P; Sansonno L; Dammacco F
    J Immunol; 2009 Nov; 183(9):6013-20. PubMed ID: 19828637
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation.
    Kittlesen DJ; Chianese-Bullock KA; Yao ZQ; Braciale TJ; Hahn YS
    J Clin Invest; 2000 Nov; 106(10):1239-49. PubMed ID: 11086025
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated Abeta protein of Alzheimer's disease.
    Joseph K; Shibayama Y; Nakazawa Y; Peerschke EI; Ghebrehiwet B; Kaplan AP
    Immunopharmacology; 1999 Sep; 43(2-3):203-10. PubMed ID: 10596854
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Platelet membrane receptors for the complement component C1q.
    Peerschke EI; Ghebrehiwet B
    Semin Hematol; 1994 Oct; 31(4):320-8. PubMed ID: 7831577
    [No Abstract]   [Full Text] [Related]  

  • 70. Expression and function of C1q receptors and C1q binding proteins at the cell surface.
    Ghiran I; Tyagi SR; Klickstein LB; Nicholson-Weller A
    Immunobiology; 2002 Sep; 205(4-5):407-20. PubMed ID: 12396003
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Kininogen binding protein p33/gC1qR is localized in the vesicular fraction of endothelial cells.
    Dedio J; Müller-Esterl W
    FEBS Lett; 1996 Dec; 399(3):255-8. PubMed ID: 8985157
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Exposure of human epidermal keratinocyte cell cultures to sulfur mustard promotes binding of complement C1q: implications for toxicity and medical countermeasures.
    Cowan FM; Broomfield CA; Smith WJ
    J Appl Toxicol; 2000 Dec; 20 Suppl 1():S77-80. PubMed ID: 11428648
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The C1q-R participates in immunoregulation and signal transduction.
    Ghebrehiwet B; Peerschke EI
    Behring Inst Mitt; 1993 Dec; (93):236-40. PubMed ID: 8172572
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification of the Raji cell membrane-derived C1q inhibitor as a receptor for human C1q. Purification and immunochemical characterization.
    Ghebrehiwet B; Silvestri L; McDevitt C
    J Exp Med; 1984 Nov; 160(5):1375-89. PubMed ID: 6436431
    [TBL] [Abstract][Full Text] [Related]  

  • 75. P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus.
    Wang Y; Finan JE; Middeldorp JM; Hayward SD
    Virology; 1997 Sep; 236(1):18-29. PubMed ID: 9299613
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification and characterisation of C1q-binding phage displayed peptides.
    Lauvrak V; Brekke OH; Ihle O; Lindqvist BH
    Biol Chem; 1997 Dec; 378(12):1509-19. PubMed ID: 9461350
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Role of complement component C1q in phagocytosis of Listeria monocytogenes by murine macrophage-like cell lines.
    Alvarez-Dominguez C; Carrasco-Marin E; Leyva-Cobian F
    Infect Immun; 1993 Sep; 61(9):3664-72. PubMed ID: 8359889
    [TBL] [Abstract][Full Text] [Related]  

  • 78. C1Q, a subunit of the first component of complement, enhances the binding of aggregated IgG to rat renal mesangial cells.
    van den Dobbelsteen ME; van der Woude FJ; Schroeijers WE; Klar-Mohamad N; van Es LA; Daha MR
    J Immunol; 1993 Oct; 151(8):4315-24. PubMed ID: 8409404
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Role of C1QBP/p32 and its Therapeutic Potential in Breast Carcinoma and other Cancers.
    Matsumoto K; Bay BH
    Curr Med Chem; 2021; 28(25):5048-5065. PubMed ID: 33390103
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Binding of activation of kinin-forming proteins on vascular endothelial cells.
    Kaplan AP; Joseph K; Shibayama Y
    Immunopharmacology; 1997 Jun; 36(2-3):201-7. PubMed ID: 9228547
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.